
Oriental Fortune Capital
Description
Oriental Fortune Capital (OFC), also known as 东方富海, is a prominent venture capital firm based in Shenzhen, China, established in 2007. The firm has grown to become a significant player in the Chinese investment landscape, specializing in venture capital investment and fund management. OFC is recognized for its strategic focus on fostering innovation and growth within key emerging sectors across China.
The firm primarily targets early-growth to growth-stage companies, demonstrating a preference for businesses with proven models and significant scaling potential. OFC's investment thesis spans several high-growth industries, including TMT (Technology, Media, and Telecommunications), high-end manufacturing, new energy and environmental protection, healthcare, and consumer services. With assets under management exceeding 20 billion RMB, which translates to approximately $2.8 billion USD, Oriental Fortune Capital possesses substantial capital deployment capabilities, enabling it to participate in significant funding rounds.
Oriental Fortune Capital boasts an impressive track record, having made over 300 investments since its inception. The firm is particularly noted for its success in guiding portfolio companies towards public listings, with more than 70 of its invested companies achieving IPOs. This strong performance underscores OFC's expertise in identifying promising ventures and providing the strategic support necessary for their long-term success. The firm's approach emphasizes deep industry research, active post-investment management, and a commitment to creating sustainable value for its portfolio companies and limited partners.
The typical first check size for Oriental Fortune Capital generally ranges from $5 million for early-growth stage opportunities to approximately $40 million for more mature growth-stage companies, reflecting their capacity to lead or co-lead substantial funding rounds.
Investor Profile
Oriental Fortune Capital has backed more than 32 startups, with 7 new investments in the last 12 months alone. The firm has led 7 rounds, about 22% of its total and boasts 27 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Software, Manufacturing, Health Care.
- Led 5 rounds in the past year.
- Typical check size: $5M – $40M.
Stage Focus
- Series B (28%)
- Series A (28%)
- Seed (19%)
- Series C (16%)
- Series Unknown (6%)
- Series D (3%)
Country Focus
- China (88%)
- United States (13%)
Industry Focus
- Software
- Manufacturing
- Health Care
- Biotechnology
- Information Technology
- Artificial Intelligence (Ai)
- Biopharma
- Pharmaceutical
- Internet
- Big Data
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.